Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02506192 · ClinicalTrials.gov registry record · Phase 2

Gulf War Illness Inflammation Reduction Trial

A Phase 2 study of Chronic Pain and Fatigue, sponsored by Minneapolis Veterans Affairs Medical Center.

Completed
Registry status
Phase 2
Development phase
83
Enrollment target
1
Study location

NCT02506192 is a Phase 2 study of Chronic Pain and Fatigue that has completed, run by Minneapolis Veterans Affairs Medical Center. The registered enrollment target is 83 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02506192, a Phase 2 study of Chronic Pain and Fatigue, has completed, sponsored by Minneapolis Veterans Affairs Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
83 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this clinical trial is to determine if treatment with an anti-inflammatory drug (delayed-release prednisone) improves the health-related quality of life (HRQOL) of veterans with Gulf War Illness (GWI). The primary outcome measure is a change from baseline of HRQOL with respect to physical functioning and symptoms. Secondary outcomes measures include changes from baseline levels of GWI-associated biomarkers of inflammation in peripheral blood, GWI-associated symptoms (chronic pain, fatigue, and cognitive impairment), and HRQOL with respect to mental functioning.

Conditions Studied

Chronic Pain Fatigue Cognitive Impairment Chronic Inflammation

Interventions

  • DRUG Placebo
  • DRUG Modified-Release Prednisone

Study Locations (1)

Minnesota

  • Minneapolis Veterans Affairs Medical Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2015-07
Est. Completion 2023-10-19
Phase Phase 2

Sponsor

Minneapolis Veterans Affairs Medical Center

28 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02506192

The ClinicalTrials.gov registry entry for NCT02506192 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (89% lower). The listed sponsor is Minneapolis Veterans Affairs Medical Center, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02506192 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02506192 about?

NCT02506192 is a clinical study titled "Gulf War Illness Inflammation Reduction Trial". The primary objective of this clinical trial is to determine if treatment with an anti-inflammatory drug (delayed-release prednisone) improves the health-related quality of life (HRQOL) of veterans with Gulf War Illness (GWI). The primary outcome measure is a change from baseline of HRQOL with respe...

What is the current status of trial NCT02506192?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 83 participants. The study started on 2015-07. Estimated completion is 2023-10-19.

What conditions does trial NCT02506192 study?

This clinical trial studies the following conditions: Chronic Pain, Fatigue, Cognitive Impairment, Chronic Inflammation.

What interventions are being tested in trial NCT02506192?

The interventions under investigation include: Placebo (DRUG), Modified-Release Prednisone (DRUG).

Who is sponsoring clinical trial NCT02506192?

This trial is sponsored by Minneapolis Veterans Affairs Medical Center, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02506192 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Pain

All registered trials for this condition

Fatigue

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.